The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMW 2021 | Patient empowerment in myeloma
Heinz Ludwig, MD, of the Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria, and Hermann Einsele, MD, FRCP, of the University of Würzburg, Würzburg, Germany, discuss the importance of patient empowerment, a critical aim of the International Myeloma Society. Prof. Ludwig explains that educated patients are better able to seek advice, respond better in difficult situations, and are better able to discuss the management of their treatment, translating into improved emotional wellbeing. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.
Disclosures
Heinz Ludwig, MD, has received research funding from Amgen and Takeda; and has received speaker’s honoraria and has participated in advisory boards for Amgen, Takeda, Sanofi, Janssen, Celgene-BMS and Seattle Genetics.
